Table 3 Top 20 differentially methylated CpG sites resulting from the comparison between BPD+T patients (N = 49) and BPD-T patients (N = 47).
CpG site | P value | Q value | B | Chr. | Chr. Position | Gene | Gene region |
|---|---|---|---|---|---|---|---|
cg01652665 | 1.25E−06 | 5.30E−01 | 3.71 | 14 | 36987722 | NKX2-1 | Body |
cg24786705 | 4.11E−06 | 8.73E−01 | 2.55 | 5 | 34500318 | IGRa | |
cg10888111 | 6.44E−06 | 9.11E−01 | 2.12 | 2 | 1637068 | PXDN | 3′UTRa |
cg15948871 | 1.01E−05 | 9.46E−01 | 1.68 | 6 | 31139620 | POU5F1 | TSS1500a |
cg05762616 | 1.41E−05 | 9.46E−01 | 1.35 | 10 | 133787150 | BNIP3 | Body |
cg13911052 | 1.47E−05 | 9.46E−01 | 1.32 | 2 | 176978909 | IGR | |
cg24846397 | 1.56E−05 | 9.46E−01 | 1.26 | 10 | 133787150 | CASP7 | TSS1500 |
cg24915915 | 1.99E−05 | 9.54E−01 | 1.02 | 2 | 231799064 | IGR | |
cg04511534 | 2.02E−05 | 9.54E−01 | 1.01 | 17 | 4463371 | GGT6 | Bodya |
cg16465769 | 2.75E−05 | 0.999985 | 0.71 | 6 | 43266151 | SLC22A7 | 1stExona |
cg01862363 | 3.21E−05 | 0.999985 | 0.56 | 17 | 8928028 | NTN1 | Body |
cg12575928 | 3.37E−05 | 0.999985 | 0.51 | 11 | 22687660 | GAS2 | TSS1500 |
cg02481697 | 3.68E−05 | 0.999985 | 0.43 | 17 | 8928012 | NTN1 | Body |
cg20989454 | 3.82E−05 | 0.999985 | 0.39 | 11 | 613478 | IRF7 | Body |
cg24319547 | 3.90E−05 | 0.999985 | 0.37 | 6 | 33168857 | SLC39A7 | 1stExon |
cg17207064 | 4.08E−05 | 0.999985 | 0.33 | 2 | 17982866 | IGR | |
cg00914033 | 4.58E−05 | 0.999985 | 0.22 | 10 | 81664698 | IGR | |
cg27190024 | 4.82E−05 | 0.999985 | 0.17 | 7 | 94034528 | COL1A2 | Body |
cg10969178 | 5.55E−05 | 0.999985 | 0.03 | 6 | 31838402 | SLC44A4 | Body |
cg06759559 | 6.37E−05 | 0.999985 | −0.10 | 1 | 7028331 | CAMTA1 | Body |